| multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. IMSG Consortium science 365, 2019 | 946* | 2019 |
| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 472 | 2021 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of clinical and translational neurology 8 (8), 1738-1744, 2021 | 105 | 2021 |
| Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial P Zamboni, L Tesio, S Galimberti, L Massacesi, F Salvi, R D’Alessandro, ... JAMA neurology 75 (1), 35-43, 2018 | 76 | 2018 |
| Cerebral nervous system vasculitis in a Covid-19 patient with pneumonia R Vaschetto, T Cena, PP Sainaghi, G Meneghetti, S Bazzano, D Vecchio, ... Journal of Clinical Neuroscience 79, 71-73, 2020 | 53 | 2020 |
| SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study MP Sormani, I Schiavetti, D Landi, L Carmisciano, N De Rossi, C Cordioli, ... Multiple Sclerosis Journal 28 (7), 1034-1040, 2022 | 43 | 2022 |
| The Yin-Yang of osteopontin in nervous system diseases: damage: versus: repair G Cappellano, D Vecchio, L Magistrelli, N Clemente, D Raineri, ... Neural regeneration research 16 (6), 1131-1137, 2021 | 40 | 2021 |
| Combined use of kappa free light chain index and isoelectrofocusing of cerebro-spinal fluid in diagnosing multiple sclerosis: performances and costs I Crespi, MG Sulas, R Mora, P Naldi, D Vecchio, C Comi, R Cantello, ... Clin Lab 63 (3), 551-559, 2017 | 39 | 2017 |
| Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis G Tackley, D Vecchio, S Hamid, M Jurynczyk, Y Kong, R Gore, K Mutch, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 165-169, 2017 | 39 | 2017 |
| Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis N Clemente, C Comi, D Raineri, G Cappellano, D Vecchio, E Orilieri, ... Frontiers in immunology 8, 321, 2017 | 37 | 2017 |
| K index is a reliable marker of intrathecal synthesis, and an alternative to IgG index in multiple sclerosis diagnostic work-up I Crespi, D Vecchio, R Serino, E Saliva, E Virgilio, MG Sulas, G Bellomo, ... Journal of Clinical Medicine 8 (4), 446, 2019 | 36 | 2019 |
| Intrathecal kappa free light chains as markers for multiple sclerosis D Vecchio, G Bellomo, R Serino, E Virgilio, M Lamonaca, U Dianzani, ... Scientific Reports 10 (1), 20329, 2020 | 35 | 2020 |
| Kappa free light chains could predict early disease course in multiple sclerosis D Vecchio, I Crespi, E Virgilio, P Naldi, MP Campisi, R Serino, U Dianzani, ... Multiple Sclerosis and Related Disorders 30, 81-84, 2019 | 30 | 2019 |
| Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis E Virgilio, D Vecchio, I Crespi, C Puricelli, P Barbero, G Galli, R Cantello, ... Journal of Neurology 269 (6), 3249-3257, 2022 | 26 | 2022 |
| A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b L Corrado, S Magri, A Bagarotti, M Carecchio, G Piscosquito, D Pareyson, ... Neuromuscular Disorders 26 (8), 516-520, 2016 | 26 | 2016 |
| Paediatric myasthenia gravis: Prognostic factors for drug free remission. PJ Vecchio D, Ramdas S, Munot P, Pitt M, Beeson D, Knight R, Rodríguez Cruz ... Neuromuscul Disord., 2019 | 23* | 2019 |
| Predictors of attack severity and duration in multiple sclerosis: a prospective study P Naldi, L Collimedaglia, D Vecchio, MG Rosso, F Perl, A Stecco, ... The Open Neurology Journal 5, 75, 2011 | 22 | 2011 |
| Untangling extracellular proteasome-osteopontin circuit dynamics in multiple sclerosis C Dianzani, D Vecchio, N Clemente, A Chiocchetti, F Martinelli Boneschi, ... Cells 8 (3), 262, 2019 | 17 | 2019 |
| Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis E Virgilio, D Vecchio, I Crespi, R Serino, R Cantello, U Dianzani, C Comi Multiple Sclerosis and Related Disorders 56, 103231, 2021 | 16 | 2021 |
| Cannabinoids in multiple sclerosis: A neurophysiological analysis D Vecchio, C Varrasi, E Virgilio, A Spagarino, P Naldi, R Cantello Acta Neurologica Scandinavica 142 (4), 333-338, 2020 | 16 | 2020 |
Roberto CantelloUniversità del Piemonte Orientale, ItaliaEmail verificata su med.uniupo.it
